Relentless Health Value

Wayne Crandall is the president and CEO of NoteSwift. Crandall's career in technology spans sales, marketing, product management, strategic development, and operations. Prior to joining the NoteSwift team, Crandall was president and CEO of CYA Technologies, and then took over as president of enChoice, which specialized in ECM systems and services, when they purchased CYA. Crandall was a co-founder, executive officer, and senior vice president of sales, marketing, and business development at Nuance Communications and was responsible for growing the company to over $120M following the acquisition of Dragon and SpeechWorks. Before Nuance, he was the European managing director of Xerox Imaging Systems, a wholly owned subsidiary of Xerox Corporation, where he established them as the market leader in document recognition software throughout EMEA and the Pacific Rim. Crandall's other career successes included Kurzweil Computer Products, Philips Information Systems, NV, Lexitron (a division of Raytheon Data Systems), and Savin Business Machines. Crandall is much funnier than this executive summary. He brings humor and wisdom to the team, and the ability to find the right person for every job. He enjoys a healthy lifestyle with his family, puppies, and, of course, the occasional round of golf. You can learn more at www.noteswift.com or send Samantha an email at [email protected].

Moore, is CEO of the health care IT analyst firm, Chilmark Research, which he founded in 2007. Chilmark Research was founded on the simple premise of conducting the best research possible that will ultimately lead to improvements in the quality of care a patient receives. Having spent many years in other industry sectors, Moore has seen the dramatic improvements possible through effective adoption and use of IT and is convinced that the same can occur in health care. A core thesis for Chilmark Research is to help guide the industry in specific subsectors of the health IT landscape by focusing on those technology domains that will be truly transformational to the delivery of care. Current areas of research include: analytics, care management and coordination, interoperability, population health management, engagement, and most recently provider-payer convergence. Prior to founding Chilmark Research, Moore led a diverse worldwide team at Dassault Systèmes, based in Paris. As head of corporate, worldwide industry and market intelligence, he worked with the executive leadership to define key global market opportunities, forecast growth, and develop critical paths to market for its numerous software products. Moore has held a number of other senior positions during his career including: SVP at analyst firm ARC Advisory Group; Research Associate at MIT; VP of Marketing for an analytical instrument company; and policy analyst for the Commonwealth of Massachusetts. An accomplished speaker, Moore has made numerous presentations on current and future IT trends and their impact to markets. Widely quoted in numerous publications, he has also been interviewed by: AMA News, CIO, CNBC, Computerworld, eWeek, Health Data Management, HealthIT News, InformationWeek, Investors Business Daily, US News & World Report, The Washington Post, and The Wall Street Journal. Learn more by going to chilmarkresearch.com and find a free copy of the 2017 Healthcare Analytics Market Trends Report during March!

John Lynn is the founder of the HealthcareScene.com network which currently consists of 10 blogs containing over 11,000 articles with John having written over half of the articles himself. These EMR and health care IT-related articles have been viewed over 18 million times. John also manages HealthcareITCentral.com and HealthcareITToday.com, the leading career Health IT job board and blog. He also organized the first of its kind conference and community focused on marketing to healthcare: HealthITMarketingConference.com. Plus, he just launched Health IT Expo, a conference focused on practical health care IT innovation. John is an advisor to multiple health care IT companies and a highly sought-after keynote speaker. John is deeply involved in social media and, in addition to his blogs, can be found on Twitter: @techguy and @ehrandhit.

Eric Haberichter is the co-founder, chairman & CEO of Access Healthnet. He has more than 25 years of health care, management and entrepreneurial experience as a highly motivated, mission-driven innovator and problem solver focused on improving the delivery and sustainability of health businesses. Early in his career, he worked as a radiation therapist and multi-modality radiographer. For 15 years, he worked within a major Wisconsin-based health care system, and in 2004, left system-based health care to work with independent physicians to develop and manage outpatient imaging and ambulatory surgical centers. In 2006, he co-founded Smart Choice MRI, the first flat-rate, quality-assured MRI provider in America. He has worked closely with employers, brokers, payers, TPAs, and medical practices to lower costs, increase quality and improve patient satisfaction. In 2013, he founded NewAmerica Health Strategies, LLC, a medical business consulting firm dedicated to creating value in health care. He was joined by Jim Kolb and Leslie Kolowith, and their experiences in serving the needs of technology start-ups and national networks aided in more fully developing the concept of Access HealthNet and its proprietary technology solution, The Super Option. Providers, employers, networks, and stakeholders can learn more about Access HealthNet at accesshealthnet.com.

Darren is Chief Executive Officer at Aduro, Inc., a human performance company that delivers habit change programs that empower people and organizations to reach their full potential. He brings a unique outlook to the health care sector, combining his experience with the intricacies of the industry with potential he sees in groundbreaking technologies, human analytics and personalized well-being. With more than 15 years of expertise in demonstrated return on population health, Darren helps companies unlock the power of a happier, healthier, and higher-performing workforce. Prior to founding Aduro, Darren has served as Associate Doctor, Clinic Director and Chief Executive Officer of Clear Chiropractic, a collection of practices in the Puget Sound Area specializing in the Blair Chiropractic Technique. Darren received his Doctor of Chiropractic from Georgia's Life University and currently serves as Chairman of the Board at Clear Chiropractic. Darren spends an increasing amount of time developing new opportunities to bring his purpose-driven approach to the larger community with support for behavior health and nutritional lifestyles. When he's not igniting Aduro's culture at a Friday Fire all-company huddle, he can be found curating crowd-pleasing playlists or traversing down the slopes at his favorite mountain hideaway.

Gary is a disrupter and founder of OM Healthcare, Inc. a health care technology startup established in 2015. He has over 18 years of business development experience and over 13 years of executive-level hospital and health system strategy expertise. Gary is a thought leader in the new frontier of health care technology, innovation, and strategy. Over the years Mr. Frazier's leadership and expertise has been sought after for strategic business planning, financial planning, growth strategy, integrated delivery systems, program development, mergers and acquisitions, and physician alignment. His roles have encompassed the rapid growth of Paladin Healthcare through hospital mergers and acquisitions, most notably a $170M acquisition of 2 Tenet hospitals in Philadelphia, PA. He served as a Principal for Vizient Consulting where he focused on physician/hospital alignment and hospital growth strategies for health systems throughout the United States. He was Vice President of Strategy and Business Development for a flagship 434-bed Dignity Health hospital in Central California where he was responsible for all strategy, growth, marketing, physician alignment, payer relations, and strategic partnerships. Before Dignity Health he managed all business development activities for hospital real estate transactions, expansions, and joint ventures in Arizona, California, and Nevada for Hammes Company Healthcare. A native of Southern California, he earned an undergraduate degree from Cal State Dominguez Hills and an MBA from UC Irvine Paul Merage School of Business. He has served as a board member of the California Hospital Association Political Action Committee (CHPAC), the Bakersfield March of Dimes, and the American Heart Association in Central California, and was Chairman of the Bakersfield Museum of Art. You can learn more at www.omhealthcare.com.

Stacey is co-president/CEO of Aventria Health Group, specializing in helping employer, pharmaceutical, device, and pharmacy clients by creating partnerships with other health care organizations. For 20 years, Stacey has innovated better-coordinated health solutions benefiting all stakeholders, and most of all, the patient. Dave is co-president/CEO of Aventria Health Group and president/CEO of Pinnacle Health Communications. He is a 27-year veteran of managed-markets marketing. After working in consumer marketing with AT&T and health care publishing with Elsevier, Dave made the move to medical advertising and communications at KI Lipton, Inc. Subsequently, he became a cofounder of Pinnacle. Dave is an accomplished strategist, providing innovative customer marketing, access, quality, and health intervention solutions for large clients and has directed the development of numerous industry-leading campaigns in primary care and specialty markets. He has supported clients in disease areas that include oncology (Bristol Myers Squibb [BMS], Novartis, Eisai), virology (BMS, Merck & Co.), pharmacy (American Pharmacists Association, Merck, Novartis), and blood disorders (Novo Nordisk), to name a few. Dave has helped more than 15 clients achieve top rankings in their respective categories. He is also an active member of the Pharmacy Quality Alliance. You can learn more about Aventria Health Group at aventriahealth.com or by emailing [email protected].

Tim Thomas, RPh president, Crystal Clear Rx Mr. Thomas is a graduate of the University of South Carolina College of Pharmacy, and has 38 years' experience as a pharmacist. His management background includes residency training and being a Director of Pharmacy at both a hospital and an HMO. For the last 25 years Mr. Thomas has been involved in managed care pharmacy with expertise in formulary, benefit design, and creating value in the pharmacy benefit. He developed a PBM in the 1990's and has held senior positions within the PBM industry. In 2008 he created Crystal Clear Rx, a pharmacy benefit consulting and research firm that is singularly focused on helping clients realize better value from their pharmacy benefit by providing optics into the PBM contracting process, data analysis, and cost effective solutions. You can learn more at www.crystalclearrx.com.

Juan Pablo founded Babyscripts in 2014 with the vision that internet - enabled medical devices would transform the delivery of pregnancy care. Since 2014, Juan Pablo has been named a Healthcare Transformer by the Startup Health Academy in New York and a Wireless Lifechanger by CTIA for his work in detecting problems in pregnancy faster. Juan Pablo is also the architect of the first "Prenatal Care Moonshot" focused on eliminating preterm birth by 2027 through mobile/digital technology and Babyscripts has been named Champions of Change in Precision Medicine by Barack Obama and the White House. Juan Pablo has raised $8.6 million in venture/angel financing for furthering his vision of a data centric model in prenatal care which includes the recent closure of a Series A of $5.5 million. He has orchestrated large partnerships with General Electric and their Healthymagination initiative and the March of Dimes specifically targeting the elimination of premature birth. He has also led the Babyscripts sales team, closing large hospital deals with more than 13 health systems around the country and successfully signing a co-development deal to build an at-risk product with Aurora Health Care in Wisconsin. Juan Pablo is a frequent speaker on the future of health care. He has spoken at the mHealth Summit on "How to Demonstrate Value in Digital/Mobile Health," at the national HIMSS conference on "Establishing ROI and Forming Partnerships: Digital Health Dating," and at the Bio+Tech conference on "Collaborating for Patient Engagement." He has pitched and won Startup Competitions at SXSW at their Barracuda Bowl and the 1776 Healthcare Challenge Cup. He has also been invited to share his thoughts on podcasts and write op-ed articles on startup fundraising and the future of health care. He was recently interviewed by Medistrategy and wrote "3 Musts for Raising Your First Round" and "Why Disruption in Health IT is like a Tiramisu Cake."

Jennifer E. Miller, PhD, is an Assistant Professor at the NYU School of Medicine and President of the nonprofit, Bioethics International. She is also the Creator of the Good Pharma Scorecard, an index that ranks all new drugs and large pharmaceutical companies on their ethics and public health performance to help recognize good practices in companies, improve trustworthiness, and incentivize change where needed. Prior to joining NYU, Dr. Miller was based at Harvard University. Dr. Miller currently serves on NYU's Pharmacy and Therapeutics Committee and Stem Cell Research Oversight IRB, as well as the J&J-NYU Compassionate-Use Advisory Committee (monitor). Previously, she served on the Center for Disease Control and Prevention's (CDC) Task Force for Pediatric Emergency Mass Critical Care, the American Medical Association's (AMA) Advanced Disaster Life Support Education Consortium, as a consultant to the United Nations Economic and Social Council, and on the PCORI-NIH Collaboratory. A prolific writer, Dr. Miller has authored over 35 articles in publications including Nature Medicine and Health Affairs. She was a Fox News pundit from 2009 to 2012 and remains a news commentator, frequently featured on CBS news, Wall Street Journal, Washington Post, Bloomberg News, Forbes, and NPR. Dr. Miller's current work explores the ethics and governance of new drugs that are researched, developed, marketed, priced, and made accessible to patients globally. She also specializes in the ethics of data sharing. 00:00 EP148: Jennifer E. Miller, PhD, Bioethics International and Creator of the Good Pharma Scorecard. 01:00 The Good Pharma Scorecard rankings for 2017. 01:40 Two 100% transparent pharma companies. 02:20 Two stats that prove that Pharma companies are improving. 03:00 Industry improvements on patient trials. 03:25 Ninety-six percent of all patient trials are available to the public. 03:45 Where there wasn't a significant improvement in disclosure in pharma.

Dr. Kyra Bobinet has five words of advice on engaging people in health: be caring, authentic, and useful. As a national speaker, bestselling author and CEO-founder of engagedIN, a neuroscience behavior design firm, Kyra devotes her life to cracking the code of WHY we engage in our health. Everyday, she and her team use neuroscience to make products and communications more engaging. For this work, Kyra received the 2015 Innovator Award from Harvard where she received her Masters in Public Health. She earned her medical degree at UCSF School of Medicine. Dr. Bobinet is the author of Well Designed Life: 10 Lessons in Brain Science and Design Thinking for a Mindful, Healthy, and Purposeful Life. She has been featured by the Wall Street Journal, New York Times, Huffington Post, ExperienceLife and NPR. She has created health start-ups, blockbuster products, health apps, big data algorithms, and evidence-based programs in mind-body & metabolic medicine. A former executive at a large payer, she has designed large-scale population health management and wellness interventions that yielded ROI for Fortune 500 companies. Dr. Bobinet co-teaches patient engagement and health design with Dr. Larry Chu at Stanford School of Medicine, and studied in BJ Fogg's behavior design lab. When she's not geeking out on neuroscience, you can find her engaged in her 160-acre training center in the Santa Cruz Mountains. You can learn more at engagedin.com and changetrainingcenter.com.

Stacey is co-president of Aventria Health Group, specializing in helping employer, pharmaceutical, device, and pharmacy clients by creating partnerships with other health care organizations. For 20 years, Stacey has innovated better-coordinated health solutions benefiting all stakeholders, and most of all, the patient. 00:00 The state of health care is fragile. 00:45 Antifragile: Things That Gain from Disorder by Nassim Nicholas 02:20 How easy it is for healthcare systems to break down. 02:40 "You can't domesticate disorder, volatility, or uncertainty." 03:15 The requirements of being an antifragile organization. 03:30 "Does everyone on the team understand the end game?" 04:45 Balancing people and processes. 05:25 "There is always judgement involved." 06:30 Overlap and quality control. 09:10 Allow for small mistakes. 11:45 The need for a feedback group. 14:15 Iatrogenic - relating to an illness caused by medical examination or treatment. 15:20 How rapid scaling slows down the ability to become antifragile. 17:10 Testing if you're doing something for the wrong reasons. 18:00 "What does the healthy business look like?" 18:20 How oligopolies make health care more fragile.

Ross Bjella, MBA is the founder and CEO of Alithias, a patient advocacy and population health analytics company serving self-insured employers, insurance companies, networks, and third party administrators. "Alithias" means "the truth" in Greek and currently has >60,000 lives with access to the platform. Ross has held senior management positions in the health care industry, including pharmaceuticals, biotech, and medical devices. Prior to Alithias, Ross served as the CEO of DDN, a leading business process outsourcer for pharma and biotech companies. Ross still consults with pharma companies about 3PL selection and resolving and supply chain issues from time to time. He has a degree in Biology from the University of Minnesota and a MBA from the University of Southern California. You can learn more at alithias.com or by emailing Ross at [email protected], or following Ross on twitter @rossbjella.

Pramod John is team leader of Vivio Health, a company that is reinventing the therapeutic use and supply chain for the specialty drug space. The Vivio Health plan solution is challenging the current framework of efficacy and extending it to true effectiveness in the real world. It also offers significant drug acquisition savings and simplicity for the patient by integrating the supply chain into a unified and data driven process. Prior to Vivio Health, Pramod was founder of Oration PBC (acquired by PokitDok) which was focused on giving back consumers control over their drug purchasing by capturing the prescription in the physician's office and providing real-time pricing options and automatic routing capabilities. Pramod was also VP of Strategy and Innovation at McKesson, the world's largest health care company. At McKesson, Pramod helped develop solutions that leveraged advanced technologies and business process improvements to optimize health care delivery systems, infrastructure, and supply chains. Earlier, Pramod founded and served as CEO of PacketMotion, Inc., a venture-funded startup in the enterprise network information and policy management industry. The company was later acquired by VMware. In addition, Pramod founded netExaminer.com, a managed-vulnerability assessment company acquired by SonicWALL (owned by Dell). Pramod earned his PhD in Electrical Engineering from the University of Illinois at Urbana-Champaign. He serves on the Boards of Mission Aviation Fellowship, a global relief organization, and 3Crosses Church in Castro Valley, CA. He also serves on the advisory board of Folia Water and as a mentor at StartX. You can learn more at www.viviohealth.com.

Erik serves as a Managing Director in the Accenture Health Client Service Group where he manages a large team of healthcare professionals within the Clinical and Health Management Services team. He serves as the Managing Director for Healthcare Provider Technology Consulting in North America, as well as Accenture's Blockchain lead across the healthcare service line and as a co-lead of Accenture's Value Based Care practice in North America. In his role, he partners with senior client executives to develop and drive healthcare transformation strategies, guide healthcare investment decisions, develop innovation roadmaps for new use of health IT, and build transformation programs in support of population health, care management, value based care, and interoperability initiatives. He also has extensive responsibilities for a diverse portfolio of sales and business development activities at major Accenture healthcare clients and leads a wide range of provider and payer sales opportunities across North America. Erik has worked for over 20 years in healthcare, including senior positions in federal, state, and commercial healthcare programs and initiatives, and served in key leadership roles within the healthcare community. He holds leadership advisory positions within the American Health Information Management Association (AHIMA), the Healthcare Information and Management Systems Society (HIMSS), and the Healthcare Financial Management Association (HFMA), and regularly speaks at industry conferences on trends influencing the healthcare industry. He received a certification as a Certified Professional in Healthcare Information & Management Systems (CHPIMS) in 2009 and became a HIMSS Fellow in 2012. You can learn more at accenture.com.

Stacey is co-president of Aventria Health Group, specializing in helping employer, pharmaceutical, device, and pharmacy clients by creating partnerships with other healthcare organizations. For 20 years, Stacey has innovated better-coordinated health solutions benefiting all stakeholders, and most of all, the patient. 00:00 The largest healthcare payers in the country. 01:45 Asking Patients to be good Healthcare Consumers. 03:30 Labeling Healthcare Consumers. 04:10 "A significant portion of the population does not consider themselves a healthcare consumer." 06:00 Identifying vs. not identifying as a Healthcare Consumer. 07:40 What most marketing behavior is motivated by. 09:10 The need for employers to demand change. 10:15 What to do to build and encourage Healthcare Consumerism. 10:25 Refer to Dave Chase's book, or his interview on our podcast, EP107. 10:50 Our podcast interview with Richard Steinhart, EP149. 11:10 The one type of person who might actually consider themselves a full-time Healthcare Consumer. 15:45 "What do we need to do to help everyone in this country realize that we are Healthcare Consumers?" 16:00 "How can we improve the scales to actually be the agents of change that everyone is depending on?"

Gidi Stein, MD, PhD. A practicing physician, researcher and serial entrepreneur. Co-founder and CEO of MedAware, dedicated to eliminate prescription errors and promote patient safety, using big-data analytics and machine-learning algorithms. Gidi also teaches medicine in Tel Aviv Medical School and treats complex patients in Rabin Medical Center, Israel. You can learn more by visiting medaware.com.

Dhruv Khullar, M.D., M.P.P. is a physician at NewYork-Presbyterian Hospital and a researcher at the Weill Cornell Department of Healthcare Policy and Research. He is also a contributor at the New York Times, where he explores the intersection of medicine, health policy, and economics. He recently worked in the ABC News Medical Unit, helping to curate and communicate evolving health stories, and was previously at the White House Office of Management and Budget (O.M.B.), focusing on Affordable Care Act implementation. Dr. Khullar completed his training in internal medicine at the Massachusetts General Hospital and Harvard Medical School, and earned his medical degree (M.D.) at the Yale School of Medicine. He also received a Masters in Public Policy (M.P.P.) from the Harvard Kennedy School, where he was a fellow at the Center for Public Leadership. His work has appeared in the New England Journal of Medicine, Journal of the American Medical Association (JAMA), New York Times, Washington Post, Wall Street Journal, USA Today, The Atlantic, Slate, and other lay and academic publications. He was recently recognized by LinkedIn as one of the Top 10 Healthcare Professionals Under 35. Thank you to Jim Klus-Salisbury for his help with this episode. @Outcomes_guru ; outcomesguru.blogspot.com You can learn more by following Dhruv's writing in the Well section of the New York Times and The Upshot.

Pramod John is team leader of VIVIO Health, a company that is reinventing the therapeutic use and supply chain for the specialty drug space. VIVIO Health's solution is challenging the current framework of efficacy and extending it to true effectiveness in the real world. It also offers significant drug acquisition savings and simplicity for the patient by integrating the supply chain into a unified and data driven process. Prior to VIVIO Health, Pramod was founder of Oration PBC (acquired by Pokitdok) which was focused on giving back consumers control over their drug purchasing by capturing the prescription in the physician's office and providing real time pricing options and automatic routing capabilities. Pramod was also VP of Strategy and Innovation at McKesson, the world's largest healthcare company. At McKesson, Pramod helped develop solutions that leveraged advanced technologies and business process improvements to optimize healthcare delivery systems, infrastructure and supply chains. Earlier, Pramod founded and served as CEO of PacketMotion, Inc., a venture-funded startup in the enterprise network information and policy management industry. The company was later acquired by VMWare. In addition, Pramod founded netExaminer.com, a managed-vulnerability assessment company acquired by SonicWALL (owned by Dell). Pramod earned his Ph.D. in Electrical Engineering from the University of Illinois at Urbana-Champaign. He serves on the Boards of Mission Aviation Fellowship, a global relief organization and 3 Crosses Church in Castro Valley, CA. He also serves on the advisory board of Folia Water and as a mentor at StartX. You can learn more at www.viviohealth.com.

Ethan Basch, MD talks today about a randomized clinical trial where 766 patients used a web-based system to self-report symptoms, triggering alerts to clinicians. The results were impressive. There are learnings and inspiration in this episode for anyone pursuing better patient outcomes, with special relevance for organizations rolling with a value-based care model. Dr. Ethan Basch is an oncologist and Director of Cancer Outcomes Research at the University of North Carolina. His research group established that up to half of patients' symptom side effects go undetected during cancer treatment and clinical trials, and that patient engagement and questionnaires substantially improve detection. His team determined that integrating web-based patient-reported symptoms into oncology clinical practice improves clinical outcomes and reduces health service utilization. His team created a system for the National Cancer Institute (NCI) to collect patient-reported side effects during cancer trials called the 'PRO-CTCAE.' Dr. Basch is also involved in efforts to bring PROs into comparative effectiveness research, routine care, and quality improvement. He is a member of the U.S. National Cancer Institute's Board of Scientific Advisors, PCORI's Methodology Committee, and is an Associate Editor at JAMA. Dr. Basch will discuss results of a widely cited randomized controlled trial testing a "PRO intervention" in routine cancer care, that was a Plenary session at the ASCO annual cancer meeting and was published in JAMA earlier this year. In this trial, 766 patients receiving routine outpatient chemotherapy for metastatic solid tumors were randomly assigned to self-report 12 common symptoms via the web, or to usual care. Treating physicians received symptom printouts at visits and nurses received email alerts when participants reported severe or worsening symptoms. Overall survival was tabulated based on medical records and Social Security Death Index data, estimated using the Kaplan-Meier method, and compared between arms using a log-rank test and Cox proportional hazards regression adjusting for age, sex, race, education level, and cancer type. Cancer types included genitourinary (32% of patients), gynecologic (23%), breast (19%), and lung cancer (26%). Survival results were assessed after a median follow up of 7 years and 517/766 (67%) of participants had died. Median overall survival in the PRO intervention arm was 5.2 months longer than the control arm (31.2 vs. 26.0 months, p=0.03). These results demonstrate that systematic symptom monitoring during outpatient chemotherapy using web-based patient-reported outcomes confers overall survival benefits. These results are being further explored in a U.S. national implementation trial.

It's rare you read an article about health tech and not see the word "interoperability" at some point, probably more than once. If that were a drinking game, we'd all be really drunk by now. Today I speak with Don Lee, a fellow podcast host about how Health Information Exchanges, otherwise known as HIEs, can assist us in the short term to get our data integration act together. This is a little bit of a reality check— blockchain and more elegant solutions might be coming, but today, right now, we need to meet quality measures. And you can't meet quality measures without having a handle on the trips to the ER, eye exams, and specialist visits that are transpiring outside the four walls of any given provider office. Don is an accomplished Health IT expert with a 20-year track record of driving value with technology. Don began his career as custom software developer and eventually built and lead a team of more than 30 engineers. Later, he was the subject matter expert, product manager and head of sales and marketing for a digital health startup that launched a SaaS-platform focused on administrative simplification in healthcare. Today, Don is President of Glide Health IT, LLC, a consulting firm that helps forward-looking organizations align their Health IT and business strategies. The firm specializes in business and product development with a focus on data aggregation, interop, analytics and quality measurement. Don is also the founder, co-host and Executive Producer of The #HCBiz Show!, a podcast dedicated to unraveling the Business of Healthcare. You can learn more by going to glidehealthit.com or [email protected] or by going to thehcbiz.com to listen to Don's podcast.

I talk with Scott Barclay today. Scott is a partner at Data Collective (DCVC), an early-stage fund that makes venture capital investments in data scientists and entrepreneurs working on hard big data problems. We discuss what it takes for an entrepreneur to succeed in the healthcare ecosystem today, including an essential ingredient: Empathy. Data Collective is a $1bn+ venture capital firm focused on early-stage investing in deep tech and data compute, based in Palo Alto and San Francisco but investing globally. Scott focuses on health and data and leads the firm's practice in Computational Care, envisioning and funding the future of special early-stage teams working on hugely ambitious problems in how health care is provided and applied with data and empathy. Current board or investment roles include Karius, Element. AI, Unity Medical, Enzyme, Medical Informatics, Noteworth, SafelyYou, PatientBank, BlueTalon, InnaMed and Subtle Medical. By background, Scott is a serial angel investor and adviser in health and data start-ups. Scott helped create and scale the first massive digital health platform (Surescripts) and served CVS Health as a GM and innovation leader across the company's health care and retail assets. Previous stints include the Boston Consulting Group, starting a capital markets desk in London for Banc of America Securities, and an MBA from Insead. Scott grew up in rural Virginia and worked many summers in a manufacturing plant, and graduated from the University of Virginia where he was militantly liberal arts and math and science. You can learn more at dcvc.com or by emailing [email protected].

Alex Akers is Vice President for Business Development with HealthCatalyst, a Utah-based, next-generation data, analytics, and decision-support company, committed to being a catalyst for massive, sustained improvements in healthcare outcomes. He has been with HealthCatalyst since 2015, primarily focusing on clients in the southeast. Alex began his career in healthcare consulting, working for KPMG and Accenture in their healthcare strategy practices, and then shifting to revenue cycle reengineering with Stockamp & Associates, where he was a Senior Manager. His passion for technology in healthcare really took off after he joined Microsoft, and was responsible for healthcare strategy in their payer segment, working on projects such as improving care giver collaboration with next generation technology, how to gamify healthcare with Xbox Kinect and consumer engagement. He spent time working with the Microsoft-GE joint venture Caradigm, and worked in sales for their analytics platform. After a stint with a San Francisco company called Grand Rounds, Alex landed at HealthCatalyst, and continues to follow his passion for bringing analytics, evidence, and better care to the US healthcare system. Alex holds a Masters in Business Administration and a Masters in Public Health (Health Policy) from the University of Alabama, Birmingham, and attended Auburn University for his undergraduate degree. He lives in Charlotte, NC with his wife Lauren. You can learn more at HealthCatalyst.com.

Leela Barham is a Health Economist by training with an MSc Health Economics from the University of York and BSc Economics from the University of Nottingham. Leela has over a decade of experience in consulting, working with clients from across the world. Leela focuses on policy and health economic issues from pharmaceutical pricing to Health Technology Assessment and more. Leela has worked with patient organizations, the NHS, a health insurer, think tanks, the pharmaceutical industry, and the medical device industry and has been an expert reviewer for the Department of Health to support on issues on innovation. Leela has also worked for the Royal College of Nursing and NERA Economic Consulting, and has been a member of the Department of Health's External Advisory Group on Payment by Results and the HFMAs Costing Special Interest Group. Leela's work has been published in a number of journals and she also regularly contributes to pharmaceutical industry magazines. She has also been a peer reviewer for journals including the European Journal of Health Economics and The Patient. You can learn more on Leela Barham's Facebook and her blog.

Mike Dendy is Vice Chairman & CEO of Advanced Medical Pricing Solutions (AMPS), an Atlanta, GA-based health care cost management company, serving the self-funded (ERISA) payer community. Since joining the Company in 2005, Mike has overseen all aspects of AMPS management, ranging from sales and marketing, to finance and client relations. AMPS has seen organic growth of over 300% over the last 5 years and has continued to increase its offerings in the health care cost containment space. AMPS clients range in size from those in the Fortune 500 to mid-sized regional employers. Prior to joining AMPS, Mike served as Chairman & CEO of HPS Paradigm Administrators Inc. from 1997 until its subsequent sale in 2004. HPS Paradigm is a health insurance Third-Party Administrator (TPA) serving corporate and government employer groups throughout the United States. During his tenure as CEO, HPS Paradigm experienced strong corporate growth, increasing on average 50% in fee income per year, while achieving industry leading EBITDA margins of over 22%. In 2000, Mike oversaw HPS' business process outsourcing (BPO) relationship with Memorial Hospital of Savannah, Georgia, which at the time was one of Georgia's largest hospital systems. Mike served as Executive Director of Memorial's TPA, HMO, PPO, UR/UM and Case Management services provided for the benefit of Chatham County area employers. From 1992-1997, Mike founded and managed Health Partners Services, Inc. (HPS), a brokerage and consulting firm, which specialized in stop-loss insurance, benefit plan design, provider negotiations, pharmacy benefit management, disease management, predictive analysis, and cost containment. HPS developed community health system plans in a number of southeastern US markets and grew consulting revenues to $600,000 annually. Mike holds 2 master's degrees, from Georgia State University in Business Administration (MBA), and Healthcare Administration (MHA) and bachelor's degrees from the University of Georgia in both Journalism and Psychology. In addition to his graduate and undergraduate achievements, Mike attended executive management programs at Harvard's Business, Public Health, and Law Schools. Mike serves on the Advisory Board for the Robinson College of Business and the School of Healthcare Administration at Georgia State University and is the former Board Chairman for the National Safe Care Campaign. Mike was awarded the School of Health Administration's Healthcare Executive of the Year in 2015. You can learn more at www.advancedpricing.com

Lisa R. Erwin is President of The E2 Group, LLC a managed markets consulting company that specializes in Medicare Part D clinical program strategic and operational expertise with a strong focus on Quality and Star Ratings. She also serves as VP of Clinical Strategies for Aventria/Pinnacle Health Communications, a managed market agency. A common theme of Ms. Erwin's 30-year pharmacy career encompassing long-term care, managed-care and hospital pharmacy has been a focus on improving the quality of medication utilization in the senior population. Most recently, Lisa held the position of Senior Director, Medicare Clinical Quality for Catamaran, a pharmacy benefit manager based in Schaumburg, Illinois. In her role at Catamaran, Lisa directed the company STAR ratings strategy and developed analytic and clinical intervention programs with an emphasis on close health plan client collaboration. She also has served as Pharmacy Director for Medicare Business at Blue Cross Blue Shield of Michigan, a provider of PDP and MAPD offerings. As Vice President, Clinical Operations for Omnicare, Inc., the largest institutional pharmacy provider in the United States, she oversaw the implementation of clinical and health management initiatives which were which were uniquely designed to serve 1.2 million residents of skilled facilities, assisted living and other institutions in 48 states. Erwin is a graduate of the University of Michigan College of Pharmacy and has been credentialed as a Certified Geriatric Pharmacist by the Commission for Certification in Geriatric Pharmacy. She has served as a member of the ASCP Task Force on Medication Therapy Management and the Editorial Advisory Board for The Consultant Pharmacist journal. Lisa held the position of co-chair of Stakeholder Advisory Panel (SAP-B) for the Pharmacy Quality Alliance (PQA) in 2015 and currently is an appointed member of the Measure Update Panel (MUP) for PQA.

In April 2013, Dr. Hunt was appointed CPHO (Chief Population Health Officer [CMO/CMIO]) for St. Vincent's Health Partners, Inc., a Physician Hospital Organization with more than 400 providers, and St. Vincent's Medical Center. Dr. Hunt provides physician leadership and direction for the planning, design and implementation of clinical information systems at St. Vincent's Health Partners, Inc. and oversees quality and utilization for its provider network. Under the leadership of Dr. Hunt, St. Vincent's Health Partners, Inc. was the first organization in the country to become accredited and re-accredited by URAC as a Clinically Integrated Network and is leading the charge in changing the face of healthcare in CT. Currently, working with organizational leaders, Dr. Hunt is engaged to develop information system infrastructure to support a super clinically integrated network. As Chief Executive Officer (2016), he is now focused to develop additional opportunities for medical management with employers and payers, enhance network contracting, and continue to support organizational transformation to value reimbursement. Dr. Hunt joined St. Vincent's Health System (SVHS) as CMIO in August 2014. He is working closely with clinical and information technology associates to transition to ongoing operations after the Cerner EMR implementation. Additionally, Dr. Hunt participates with the Valued Care Alliance [VCA] (a newly formed six hospital consortium in Connecticut in which St. Vincent's Medical Center is a founding member) to establish system-wide population management infrastructure. The VCA has been recognized as a leading advanced network by Connecticut and participates with the Community and Clinical Integration Program, and awarded the Accountable Health Communities (AHC) model grant by CMS. Dr. Michael Hunt, EP133. Defining Attribution. How do you define Fee-for-Service Attribution? How do you align your operations to manage and maximize all sides of your business? "Depending on your business model and how you look at those attributions, you define success."

Stacey is co-president of Aventria Health Group, specializing in helping employer, pharmaceutical, device and pharmacy clients by creating partnerships with other health care organizations. For twenty years, Stacey has innovated better-coordinated health solutions benefiting all stakeholders, and most of all, the patient. 00:00 Incrementalism - Worth it? 01:51 "The CEO's Guide to Restoring the American Dream: How to Deliver World-Class Healthcare to Your Employees at Half the Cost," by Dave Chase. 02:25 What would Amazon do differently by building a System of Care? 03:15 Does our conviction about the current Healthcare System stop us from creating something better? 04:15 Divestiture Aversion - Why a Healthcare reboot isn't such a bad idea. 11:00 "What are the ramifications if Amazon enters more deeply into that hybrid online-inperson space?" 12:45 How did we get where we are now? - Check out INBW13, INBW12, INBW10. 13:00 Only three stakeholders that have an invested interest in keeping Healthcare Value high: Employers, Taxpayers, and Consumers. 13:20 Large Employers as the only stakeholder with the power to make change in Healthcare. 16:50 Who is going to be behind such a reboot? 19:00 How onsite clinics might be the future and greatly benefit reducing healthcare costs. 20:00 The divorce of patient care and industry needs. 21:50 "Employers don't just have skin in the game, they have entire bodyparts." 22:50 "Employers have a larger call; healthcare is a means to an end for them."

Mr. Steinhart has had a distinguished career as an entrepreneur, investor and executive in the healthcare industry. He has been instrumental in starting or investing in many technology-based companies, several of which have developed products that have become the standard of care in their respective markets. Currently Mr. Steinhart sits on the Board of Directors of Actinium Pharmaceuticals, Inc., a New York-based biopharmaceutical company developing innovative targeted therapies for patients with cancers lacking effective treatment options. Mr. Steinhart is also a member of the Board of Directors of Atossa Genetics, a clinical-stage Seattle-based drug- company that is developing novel, proprietary therapeutics and delivery methods for breast cancer and other breast conditions. Earlier in his career Mr. Steinhart was the Sr. Vice President and CFO at MELA Sciences, a company that received FDA approval for and marketed the world's only non-invasive Melanoma detector. Prior to MELA Sciences, he was a General Partner and CFO at CW Group, Inc., the country's first venture capital firm focused solely on medical technology and biopharmaceutical companies. Mr. Steinhart has also had significant experience in municipal government. He introduced the first mandatory Health Saving Account (HSA) insurance coverage for municipal works in the state of Connecticut. By working with union representatives and insurance company executives, Mr. Steinhart was able to craft a program that delivered high quality affordable healthcare benefits to union workers, while at the same time saving his local municipality millions of dollars in premiums. This program has been widely emulated by many of the 169 towns and cities in Connecticut. Mr. Steinhart currently live in Ridgefield Connecticut with his wife and two sons. He can be reached by e-mail at [email protected]

Jennifer E. Miller, PhD, is an Assistant Professor at the NYU School of Medicine and President of the nonprofit, Bioethics International. She is also the Creator of the Good Pharma Scorecard, an index that ranks all new drugs and large pharmaceutical companies on their ethics and public health performance to help recognize good practices in companies, improve trustworthiness, and incentivize change where needed. Prior to joining NYU, Dr. Miller was based at Harvard University. Dr. Miller currently serves on NYU's Pharmacy and Therapeutics Committee and Stem Cell Research Oversight IRB, as well as the J&J-NYU Compassionate-Use Advisory Committee (monitor). Previously, she served on the Center for Disease Control and Prevention's (CDC) Task Force for Pediatric Emergency Mass Critical Care, the American Medical Association's (AMA) Advanced Disaster Life Support Education Consortium, as a consultant to the United Nations Economic and Social Council, and on the PCORI-NIH Collaboratory. A prolific writer, Dr. Miller has authored over 35 publications, including for Nature Medicine and Health Affairs. She was a Fox News pundit from 2009 to 2012 and remains a news commentator, frequently featured on CBS news, Wall Street Journal, Washington Post, Bloomberg News, Forbes, and NPR. Dr. Miller's current work explores the ethics and governance of new drugs that are researched, developed, marketed, priced, and made accessible to patients globally. She also specializes in the ethics of data sharing. You can learn more at www.bioethicsinternational.org and view the Good Pharma Scorecard.

Founder and CEO of Fit4D, David Weingard David is a diabetes patient who was diagnosed with Type 1 diabetes at the age of 36 while training for a survival race. A veteran of numerous running and triathlon races (including Ironman triathlons consisting of a 2.4M swim, 112M bike and 26.2M run), David committed to rebuild his life and provide positive energy to the diabetes community while coping with the condition on a 24/7 basis. Beginning with shorter races, he gradually learned how to successfully race triathlons with diabetes and within a year, completed the famous Escape from Alcatraz Triathlon in San Francisco Bay. He then began racing Ironman triathlons again – though this time, working through the delicate balance between insulin, food, nutrition and exercise. Through these races, David has fundraised extensively on behalf of the Juvenile diabetes Research Foundation's (JDRF) New York City Chapter. David's personal experience receiving meaningful education and support from a Certified Diabetes Educator (CDE) sparked the idea for Fit4D to leverage technology to scale the patient reach of adherence and outcome improvement programs for pharmaceutical, payer and provider organizations. In 2008, David left Microsoft to found Fit4D, building on his career as an executive in the technology sector. As the founder and CEO of Fit4D, David received the PM360 Elite Entrepreneur award for transforming the diabetes landscape. Under David's leadership PM360 also named Fit4D one of the top innovative healthcare startups in 2015, while ePharma named Fit4D its 2016 audience winner of the Disruptive Technology Showcase and Innovations Challenge. David is transforming the diabetes landscape and improving people's health in the real world every day. David was selected as the Keynote Speaker for the American Diabetes Association's largest fundraising event, Step Out: Walk to Stop Diabetes, 2016. David has given back to the diabetes community by coaching the JDRF Ride to Cure Diabetes and the American Diabetes Association's Tour De Cure many times, and gives back to the entrepreneur community by guiding emerging health technology founders. As a chosen finalist for the Novo Nordisk-Lyfebulb Patient Entrepreneur award, David participated in a panel on patient-centric innovation, sharing his message of hope to an international audience. Most recently, David was the recipient of the first-ever Kate Granger Compassionate Care Award, spotlighting individual contributions to high-tech/high-touch care and awarded to those who demonstrate compassionate care in this area. You can find out more at www.fit4d.com or email [email protected]

Tom Kottler is co-founder and Chief Executive Officer of HealthPrize Technologies, which uses gamification, behavioral economics and consumer marketing concepts to engage and motivate patients. HealthPrize works with top and emerging life science companies to inspire patient loyalty, maximize medication adherence and improve health literacy. Kottler has led multiple high-growth organizations during his career, including Advanced BioHealing, which was acquired by Shire for $750 million, and MedAptus, an innovative healthcare IT company based in Boston, Mass. You can learn more at www.healthprize.com

Andrew Schorr is a medical journalist who was diagnosed with chronic lymphocytic leukemia (CLL) in 1996 and has remained in remission since then. He is the founder of HealthTalk.com, PatientPower.info and PatientPower.eu. He is board chair of the Patient Empowerment Foundation in Europe. He is also the author of The Web-Savvy Patient: An Insider's Guide to Navigating the Internet When Facing Medical Crisis, which was published in 2011. Andrew is a graduate of UNC-Chapel Hill and holds a master's degree in journalism from Columbia University.

Julie is an executive pharmaceutical leader with over 20 years of experience across all phases of development both on the commercial and research sides of the organization. She leverages her Masters in Business Administration and Doctorate of Pharmacy to develop and deliver strategic patient-centric value propositions to optimize patient access and improve outcomes in patients with difficult to treat diseases leading to longer, healthier, and more productive lives. Her years of experience in global and US payer markets provides Julie with intimate knowledge of the current and evolving payer and market access landscape in the US and around the globe. She has led the development and execution of several outcomes-based contracts with 3 of the largest national payer organizations in the US. Dr. Locklear is well published, having authored >30 publications in peer-reviewed journals and >60 peer-reviewed abstracts presented as posters at major scientific congresses.

Dr. Nick is a leader in Digital Healthcare and Innovation, and former Chief Medical Officer for Dell. He provides strategic insights and guidance to support healthcare organizations, medical professionals and patients through information-enabled healthcare. He brings an incremental approach to developing successful strategies and applying technology to achieve a technology environment that is interconnected, efficient and patient-focused. He is a highly sought out speaker on the practical and futuristic use of healthcare technology and how it can improve patient engagement and wellness. Dr. Terheyden brings a distinctive blend of medical practitioner and business strategist, both national and international, to the realm of digital healthcare technology. A graduate of the Royal Free Hospital School of Medicine, University of London, Dr. van Terheyden is a pioneering creator in the evolution of healthcare technology. After several years as a medical practitioner in London and Australia, he joined an international who's who in healthcare, academia and business, in the development of the first electronic health record in the early 1990's and later, as a business leader in one of the first speech recognition companies. His rare combination of patience, creativity, skill and intrinsic business ethics has led him to a diverse career in healthcare with some of the most prestigious hospitals, consulting firms, and technology companies. His focus is on small improvements we can learn from other industries and can be applied in healthcare to bring immediate value, but that also add up to the big leap we need and are all looking for - focusing on evolution not revolution. His most recent position was Chief Medical Officer for Dell where he was responsible for providing strategic insight establishing the organization as an innovator in healthcare technology and Digital Health. In addition to writing and lecturing on futuristic trends in healthcare technology, his advice and counsel is sought by hospitals, physicians and other allied healthcare professionals all of whom are trying to figure out how to integrate and use technology to make the healthcare system work from the perspectives of quality and financial success. Dr. van Terheyden pays attention not just to processes and systems, but to people. His ability to speak in terms people can actually understand makes him a sought-out speaker. Specialties: Digital Health, Internet of Medical Things (IoT), Medical Home, Healthcare Informatics, Speech Recognition, Natural Language Processing, Mobile Health, Social Media.

Brian Yarnell is President and Founder of Bluestream Health, a New York-based healthtech startup delivering an on-demand platform for remote medical expertise. Prior to launching Bluestream Health, he founded, grew and sold StarlingHealth, a startup that replaced nurse call systems with multilingual touchscreen interfaces and a clinical workflow platform. Brian is an entrepreneur with more than 15 years of experience creating and commercializing enterprise software platforms across multiple verticals. He is an Advisor to ElabNYC, a member of the Connected Health Institute Advisory Board of VNA Health Group, and mentor to students at CCNY's Zahn Innovation Center. Brian earned a BS in Marketing and International Business from The Pennsylvania State University. You can learn more at bluestreamhealth.com or email Brian at [email protected].

Stacey is co-president of Aventria Health Group, a marcomm agency helping employers, payers, pharma and pharmacies develop and leverage partnerships with other health care organizations. For twenty years, Stacey has used her expertise to innovate inspiring collaborative health solutions benefiting all stakeholders, and most of all the patient. 00:00 Elisabeth Rosenthal, "An American Sickness: How Healthcare Became Big Business." 02:25 Look at the bills your insurance company is paying. 02:45 "All of your out-of-pockets are a function of how much your insurance is paying on your behalf." 03:20 "If no one is questioning what those costs are, then providers will fill in whatever they think they can get." 04:05 Is your practice owned by a hospital, or licensed as a surgery center? 04:35 Ask your physician to only refer you to other physicians in your network. 05:00 Request that labs be in-network. 06:15 Ask in advance how much a procedure will cost. 07:30 "It's up to us to inform our Physicians about costs." 07:50 "How will this test or exam change my treatment?" 08:20 Ask which blood test or exam they're taking and why. 09:00 "Where will this test or surgery be performed, and how does that place affect the price?" 10:00 "Who else will be involved in my treatment, and will I be getting a separate bill?" 11:25 "Watchful Waiting," - the Value in waiting to seek treatment. 13:30 Price Transparency. 14:45 Fight back on Gag Clauses.

Lorrie Carr joined ZappRx in April 2016 as Chief Commercial Officer. She has over 20 years' experience in the health care industry – primarily focused in the pharma/biotech and specialty pharmacy industries. Just prior to joining ZappRx, Ms. Carr was the Divisional VP of Enterprise Specialty Sales and Product Management for Walgreens Specialty Pharmacy. Ms. Carr transformed the strategy, operations and deployment of the over 300-person Specialty and Infusion sales teams resulting in consistent double-digit year over year growth for the multi-billion-dollar business. In addition, she created, built and successfully led the product management team which developed and executed on growth strategies for high priority specialty disease areas. Prior to Walgreens, Ms. Carr was the Head of U.S. / Global Market Access for Millennium Pharmaceuticals (now Takeda Oncology) where she built the first Reimbursement & Market Access team for the company, advised global R&D on access related trial design decisions, led the European patient access strategy, and played a material role in developing pricing, contracting, distribution and patient assistance program strategies for pipeline and marketed products. She started her pharmaceutical career at Schering-Plough (now Merck) where she held various roles in account management, and ultimately, became a senior leader of the US Market Access marketing group. Ms. Carr received her Bachelor's degree from Columbia College and holds her MBA from UMASS Isenberg School of Management. 00:00 Specialty Pharmaceutical Products. 02:30 Inefficiencies in the system. 04:00 The paper-fill process for Patient Prescription/Enrollment with Specialty Pharmacies. 06:30 Enrollment Forms for prescription drugs filled at Specialty Pharmacies. 10:20 The overwhelming cost and administrative overhead for Providers having to keep track of all of these forms. 13:00 How the process changes for Providers with ZappRx 19:00 Getting the drug out to the patient without conflict. 20:00 Double check for patients and Specialty Pharmacy. 22:00 Why ZappRx is collaborative, not competitive. 23:30 ZappRx's work on the Provider side. 24:25 Gathering Data at the front-end of the prescribing process. 25:15 ZappRx's long-term business model. 25:30 Missing Data in the healthcare and pharmacy markets. 27:45 Aggregating data and identifying trends. 28:30 ZappRx's five key focus Disease Areas. 30:00 You can learn more about ZappRx at www.zapprx.com.

Sajid Ahmed is the Chief Information and Innovation Officer of Martin Luther King, Jr. Community Hospital in South Los Angeles. He is leading the new hospital's $70 million health information technology initiative and launching an innovation hub on the 42-acre MLK Medical Center Campus. Mr. Ahmed is a true innovator and pioneer in healthcare information systems. He has unparalleled experience in all aspects of using computer technology and web-based applications to deliver the best quality of medical care to patients, facilitate collaboration among multiple and diverse medical care providers and systems, and increase the efficiency of healthcare environments. He is also a highly respected consultant on innovation, and frequently lectures about entrepreneurism and information technology for healthcare environments. Mr. Ahmed was formerly the director of health information technology and innovation for L.A. Care Health Plan, the nation's largest public plan serving more than one million Los Angeles County residents through free or low-cost health insurance programs. He was responsible for coordinating, managing and integrating healthcare information technology and eHealth initiatives among multiple users and partners. This includes all medical care providers, community organizations, government agencies, vendors and other health information technologies. He served as vice chair of the organization's Technical Advisory Committee. One of his most significant contributions to L.A. Care is the creation of HITEC-LA (Health Information Technology Regional Extension Center for Los Angeles County) for electronic health record adoption and implementation for providers throughout L.A. County. Before leaving L.A. Care, Mr. Ahmed created and launched eConsult in partnership with the Los Angeles County Department of Health Services. eConsult is an innovative telehealth system that allows for virtual consultations and collaboration with specialists. As eConsult expands throughout California and accumulates thousands of end users, it is becoming a national model for the standard for care coordination and access to specialty care in the U.S. Prior to eConsult, Mr. Ahmed was the visionary behind SelfMD™; developed the ELICIT™ concept (emulating logical inferences of cognition and intuition theory), and was instrumental in getting the U.S. Military Medical Command to adopt advanced diagnostic technologies and electronic health records systems. He also served as co-chair on health IT committees for California's Health and Human Services Agency, helping to draft the state's $38.8 million Health Information Technology strategic plan. Mr. Ahmed has lectured at the University of California, Los Angeles (UCLA) Fielding School of Public Health, and as a guest lecturer at the California Institute of Technology (CalTech), University of Southern California (USC) and CalState LA. He was honored for his teaching at the USC Lloyd Greif Center for Entrepreneurial Studies, and also was a finalist for the Advanced Business League (ABL) Innovative Leadership Award on Healthcare. Currently he is an advisory board member of the California Health eQuality Initiative based at the University of California, Davis. Earlier this year he was lauded as CIO of the Year by the Los Angeles Business Journal. Chief Information & Innovations Officer, Martin Luther King Jr. Hospital, Healthcare Corporation Former Senior Director, Health Information Technology & Innovation for L.A. Care Health Plan Former Executive Director & Founder of HITEC-LA, LA County's Regional Extension Center for EHR Adoption Director, Safety Net eConsult Program for Los Angeles Former Interim Chief Information Officer, Healthcare First South LA - ACO

Roy Rosin is Chief Innovation Officer at Penn Medicine, working to rapidly design, test and implement high impact health care delivery practices. His team crafts interventions to achieve dramatically improved patient outcomes, experience and high value care. In the past four years they have driven measurable progress in readmission rates, frequent use of the ER, medication adherence, screening rates, antibiotic stewardship and making a population normotensive, among other advances. Previously, Roy served as the first VP of Innovation for Intuit, a leading software company best known for Quicken and TurboTax. In this role, he led changes in how Intuit managed new business creation, allowing teams to experiment quickly at low cost. Intuit now consistently appears on Forbes' list of the most innovative companies in the world. Prior to leading innovation, Roy's Quicken team achieved record profitability and product leadership while growing to 14 million consumers. Roy's 18 years with Intuit spanned the early years in software to their emergence as a leading SaaS provider. Outside of his Penn role, Roy advises startups and Fortune 100 companies building new technology businesses focused on making a meaningful difference in people's lives. Roy received his MBA from Stanford and graduated with honors from Harvard College. Find out more information at http://healthcareinnovation.upenn.edu/.

Dr LaFountain is a healthcare strategist, neuroscientist and author of "How Patients Think: A science-based strategy for patient engagement and population health." She is the CEO of Mind Field Solutions Corporation, a firm specializing in the application of cognitive neuroscience to health behavior and patient engagement. The Cleveland Clinic has described her neuroscience approach to patient engagement as "a stunning innovation in healthcare," and "a pathway for transformation." Harvard Medical School describes her work as "providing a scientific approach to patient care that is long overdue." Her business was described as "one to watch" by Mid-Atlantic Diamond Ventures. Prior to establishing Mind Field Solutions, she worked for AstraZeneca Pharmaceuticals where she led consumer research and analytics for the oncology portfolio. She received numerous awards for her work in understanding consumer behavior including the "Consumer Marketing Excellence" award and "Best Commercial Innovation." She has chaired international conferences on patient engagement for many years and is recognized as an industry expert in patient behavior. She earned a PhD for her research in Pre-Frontal Cortex Executive Functioning which received the accolade of having "measured the immeasurable," by Imperial College, London. Before moving to the United States, she was a lecturer at The University of Liverpool, specializing in Cognitive Neuroscience, Health Behavior, Research and Statistics. She is a frequent lecturer on Wharton's Healthcare MBA program. She is the Past President of the Mid-Atlantic Healthcare Business Woman's Association. She is a fellow of the American Psychological Association as well as the British Psychological Society, and a scientific reviewer for the International Society for Pharmaco-economic Outcomes Research. She lives in Philadelphia with her husband Andy and five children. You can find out more information at howpatientsthink.org, or by reading the book How Patients Think.

Stacey is co-president of Aventria Health Group, a marketing agency specializing in helping pharmaceutical, device and pharmacy clients gain access to patients by creating and leveraging partnerships with other health care organizations. For twenty years, Stacey has innovated better-coordinated health solutions benefiting all stakeholders, and most of all, the patient. This episode compares how six authors approach the topics of Healthcare, Business, Medicine, Aging Populations, and Digital Health. In the initial list of books announced in the podcast, The Digital Doctor is left out. The complete list of books discussed, all of which have redeeming qualities, are: 1. Catastrophic Care: How American Healthcare Killed My Father and How We Can Fix It by David Goldhill 2. An American Sickness: How Healthcare Became Big Business and How to Take It Back by Elisabeth Rosenthal 3. America's Bitter Pill: Money, Politics, Backroom Deals, and the Fight to Fix Our Broken Healthcare System by Steven Brill 4. The Patient Will See You Now: The Future of Medicine is In Your Hands by Eric Topol 5. Curing Medicare: A Doctor's View On How Our Healthcare System is Failing Older Americans and How We Can Fix It by Andy Lazris MD 6. The Digital Doctor: Hope, Hype, and Harm at the Dawn of Medicine's Computer Age by Robert Wachter 00:00 Catastrophic Care: Consumerism and Conservatism. 02:00 Diverging from normal Economic Systems. 02:30 The island of Healthcare. 02:45 More Suppliers, More Demand? 06:00 Listen to Inbetweenisode 10 for more information. 08:45 Health Insurance vs. Healthcare. 10:00 What the Market will bear is the price that's being charged. 10:50 Single Payer Systems; Public Hospitals? 12:00 The 80/20 Healthcare Problem. 13:00 How a Social Safety Net impacts Health Outcomes in Single-Payer Systems. 15:15 An American Sickness: Exploiting Charges for Healthcare Services. 17:20 Laws of Healthcare Business. 18:00 Curing Medicare: The Physician's standpoint. 19:15 The Moral Hazard of Ignoring the Aggressive approach to Healthcare. 22:40 America's Bitter Pill: The Politics behind the American Healthcare System. 25:00 The Patient Will See You Now: Optimism in Innovation and Invention in Healthcare. 26:25 "Are you a Disruptor, or are you part of the problem?" 28:15 The Digital Doctor: What Health Tech can bring, and the Cost of that Technology.

Dr. Josh Luke, FACHE Adjunct Faculty, University of Southern California, Sol Price School of Public Policy Founder, National Readmission Prevention Collaborative & National Bundled Payment Collaborative Author: Ex-Acute: A former hospital CEO tells all about what's wrong with American healthcare Author: Readmission Prevention: Solutions Across the Provider Continuum Chief Strategy Officer, Compliagent/Nelson Hardiman Healthcare Law Dr. Josh Luke, The Voice of American Healthcare, is a best-selling author, hospital CEO, healthcare futurist, thought-leader and international motivational speaker. He is an experienced hospital CEO, health system Vice President and nursing home administrator. He is regarded as a "futurist" on value based care and how it will shape the continuum of care and has been described as an as an innovator, forward-thinking and a strategist on teaching ACO's, Bundles, acute hospitals and post-acute leaders how to position themselves for revenue growth in a post-ACA model. In October 2016 Luke founded the National Association of Residential Care Facilities (NARCF). He currently serves as Chief Strategy Officer for Nelson Hardiman Healthcare Law and its subsidiary consulting firm, Compliagent. Having uniquely held executive positions in both acute and post-acute settings, Dr. Luke was selected to author the book Readmission Prevention: Solutions Across the Provider Continuum published by the American College of Healthcare Executives, the best-selling book from Health Administration Press in 2015. In 2016, Xlibris publishing released Luke's first book written for the mainstream public, Ex-Acute: A former hospital CEO tells all on what's wrong with American healthcare, What every American needs to know. In 2016 Luke is conducting an international book promotion tour. In 2013, Luke was named Vice President of Post Acute Services for Torrance Memorial Health System. In that role he designed a population management strategy (Total Wellness Torrance), working with the ACO, Bundled Payment & IPA teams. TWT and its Post Acute Network received the 2013 Excellence in Programming award from CAHF. His broad range of prior experience with some of the leading companies in healthcare, positioned him well to be an expert on readmission prevention and care coordination. He served as the CEO of multiple acute hospitals in California, as CEO of HealthSouth Las Vegas (acute rehab hospital), Administrator in the Skilled Nursing Division of Kindred, and had direct oversight of home health and hospice services in his health system Vice president role. Dr. Luke founded the National Readmission Prevention Collaborative in October 2013 (nationalreadmissionprevention.com) to showcase Best Practice integration models and the National Bundled Payment Collaborative in 2015. Dr. Luke serves as adjunct faculty at the University of Southern California, Sol Price School of Public Policy and formerly at California State University, Long Beach in the Healthcare Administration Department. He previously instructed at California State University, Fullerton. Dr. Luke has a Ph.D. in Educational Leadership, is a Lean Six Sigma Black Belt, served as a Lean Mentor and Project Chair, is a Fellow with ACHE and is past Chair for the Cal Optima Provider Advisory Committee. Recent and past board appointments include The California Hospital Association Center for Post Acute Board of Directors, Alzheimer's Orange County, the Hospital Association of Southern California, Healthcare Executives of Southern California, CSULB Healthcare Administration Advisory Board and Hospice Care of California. He is also a licensed SNF & RCFE Administrator and preceptor. You can find out more information at nationalreadmissionprevention.com, joshluke.org, and by connecting with Josh on LinkedIn.

David W. Bates, M.D., M.Sc. Chief, Division of General Internal Medicine, Brigham and Women's Hospital Medical Director of Clinical and Quality Analysis, Partners HealthCare Dr. Bates is an internationally renowned expert in patient safety, using information technology to improve care, quality-of-care, cost-effectiveness, and outcomes assessment in medical practice. He is a Professor of Medicine at Harvard Medical School, and a Professor of Health Policy and Management at the Harvard School of Public Health, where he co-directs the Program in Clinical Effectiveness. He directs the Center for Patient Safety Research and Practice at Brigham and Women's Hospital. He served as external program lead for research in the World Health Organization's Global Alliance for Patient Safety and is the immediate past president of the International Society for Quality in Healthcare (ISQua) and the editor of the Journal of Patient Safety. He has been elected to the Institute of Medicine, the American Society for Clinical Investigation, the Association of American Physicians and the American College of Medical Informatics, and was chairman of the Board of the American Medical Informatics Association. He has published over 700 peer-reviewed papers and has an h-index of 115, which ranks him among the 400 most cited biomedical researchers of any type. Websites: www.patientsafetyresearch.org You can learn more by emailing David directly at [email protected].

David is the Chief Development Officer where he is responsible for expanding the firm's influence in the health care market. Since joining Leavitt Partners, David has advised clients in areas of government activity, insurance market reforms, economic changes to the health care payment system, and alliances. He specifically helped establish the Private Exchange Coalition and has led multiple other collaboratives that aggregate parties with common interests to achieve statutory, regulatory, or market objectives. David also established and expanded Leavitt Partners Chicago operation. David has a masters of statistics with an emphasis in econometrics from the University of Utah. He also served on the Utah State Board of Regents, where he shared some collective stewardship over Utah's publicly funded institutions of higher education. You can find out more information at www.leavittpartners.com.

Melissa McCool is the co-founder and CEO of Stellicare Corporation. In 2009, Melissa developed Symptom Targeted Intervention (STI), a clinical program used in thousands of US medical clinics to improve the behavioral determinants of health. Since then, she has written and produced numerous articles, videos, and books and has trained thousands of clinicians around the US and Canada on how to implement STI into clinical practice. Melissa is also an EMDR-trained psychotherapist with a specialization in treating trauma. Her degrees are from UCSD and Columbia University.

Dr. Hunt graduated from the University of Osteopathic Medicine and Health Sciences, Des Moines, Iowa and completed his residency in Pediatrics. During his military service, Dr. Hunt's held key leadership positions. As Chief Medical Information Officer, he has implemented 'Epic' and 'Cerner' EMRs. He is Board Certified in pediatrics and received a Master of Science in Medical Informatics. In April 2013, Dr. Hunt was appointed CPHO (Chief Population Health Officer [CMO/CMIO]) for St. Vincent's Health Partners, Inc., a Physician Hospital Organization with more than 400 providers, and St. Vincent's Medical Center. Dr. Hunt provides physician leadership and direction for the planning, design and implementation of clinical information systems at St. Vincent's Health Partners, Inc. and oversees quality and utilization for its provider network. Under the leadership of Dr. Hunt, St. Vincent's Health Partners, Inc. was the first organization in the country to become accredited and re-accredited by URAC as a Clinically Integrated Network and is leading the charge in changing the face of healthcare in CT. Currently, working with organizational leaders, Dr. Hunt is engaged to develop information system infrastructure to support a super clinically integrated network. As Chief Executive Officer (2016), he is now focused to develop additional opportunities for medical management with employers and payers, enhance network contracting, and continue to support organizational transformation to value reimbursement. Dr. Hunt joined St. Vincent's Health System (SVHS) as CMIO in August 2014. He is working closely with clinical and information technology associates to transition to ongoing operations after the Cerner EMR implementation. Additionally, Dr. Hunt participates with the Valued Care Alliance [VCA] (a newly formed six hospital consortium in Connecticut in which St. Vincent's Medical Center is a founding member) to establish system-wide population management infrastructure. The VCA has been recognized as a leading advanced network by Connecticut and participates with the Community and Clinical Integration Program, and awarded the Accountable Health Communities (AHC) model grant by CMS.

Darren Pearce serves as the Chief Administrative Officer for Ambulatory & Retail Services for Navicent Health, an academic medical system including a Level 1 Trauma center, multiple rural acute outposts and post-acute offerings located in Central Georgia. A proud Navy veteran, Darren Pearce started his early career as a Registered Nurse and went on to complete his MBA as he transitioned from direct clinical work into the business of healthcare. Working for Navicent for close to 10 years, he served in various healthcare executive leadership roles across the Navicent Health system of care including ambulatory/retail, rural-setting acute care and post-acute rehabilitation where he has consistently demonstrated an innate ability to challenge the current state and create practical innovations to address both quality and service improvements. Darren's emphasis on mentoring frontline change agents to address culture barriers for improved clinical and business outcomes has become his trademark. His results in the areas of financial and quality improvements in rural settings has been recognized nationally.

Bringing over ten years of experience as an entrepreneur and consultant to CipherHealth, Zach Silverzweig works with hospitals to achieve patient-centered care through the elegant application of innovative and forward-thinking solutions. He leads CipherHealth's product and development teams, managing the solution lifecycle from concept to napkin to prototype to launch to profitability. Zach also plays a key role in managing the company's financial operations and helping to shape CipherHealth's corporate architecture. Prior to CipherHealth, Zach served as founder and CEO of an online fitness planning website. Zach has worked as a consultant at Pace Harmon and Archstone Consulting, where he helped healthcare payors, providers and the Fortune 500, improve operations, increase performance, and reduce costs.